Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing - PubMed (original) (raw)
. 1995 Oct 15;55(20):4531-5.
Affiliations
- PMID: 7553622
Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing
M Gonzalez-Zulueta et al. Cancer Res. 1995.
Abstract
Loss of heterozygosity on 9p21, where the p16/CDKN2 tumor suppressor and the p15INK4B cell cycle regulator genes are located, is a common genetic alteration in bladder cancer. However, it has been difficult to demonstrate homozygous deletions and intragenic mutations in either of these two genes in primary transitional cell carcinomas (TCC) of the bladder. Similarly, colon cancer-derived cell lines have shown no homozygous deletions of the p16/CDKN2 locus in contrast to a wide variety of tumor-derived cell lines. We have investigated abnormal methylation of the 5' CpG islands of the p16/CDKN2 and p15INK4B genes as an alternative mechanism of inactivation of these genes in bladder and colon cancers. De novo methylation of the 5' CpG island of p16/CDKN2 was observed in 12 of 18 (67%) uncultured bladder TCCs and in 2 of 3 (67%) bladder cell lines. In contrast, only 1 of 10 (10%) colon carcinomas showed methylation of the 5' CpG island of p16/CDKN2. It was striking to find that this region was extensively methylated and the gene not expressed in the normal colonic mucosa of 6 of 10 (60%) patients with colon cancer, whereas 5 of the corresponding colon tumors showed no methylation and high levels of p16/CDKN2 expression. Our data show a significant correlation (P = 0.00001, two-sided) between the absence of p16/CDKN2 expression and methylation of its 5' CpG island in bladder tumors, cell lines, and normal colon mucosa. In contrast, no association was observed between expression and methylation status of the 5' CpG island of p15INK4B. Our results suggest that the p16/CDKN2 tumor suppressor gene may be inactivated by methylation of its 5' CpG island in TCCs of the bladder. We also present evidence of methylation of the 5' CpG island in this autosomal gene in normal colonic tissue.
Similar articles
- Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.
Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, Sidransky D, Baylin SB. Herman JG, et al. Cancer Res. 1995 Oct 15;55(20):4525-30. Cancer Res. 1995. PMID: 7553621 - p15(INK4b) in bladder carcinomas: decreased expression in superficial tumours.
Le Frère-Belda MA, Cappellen D, Daher A, Gil-Diez-de-Medina S, Besse F, Abbou CC, Thiery JP, Zafrani ES, Chopin DK, Radvanyi F. Le Frère-Belda MA, et al. Br J Cancer. 2001 Nov 16;85(10):1515-21. doi: 10.1054/bjoc.2001.2106. Br J Cancer. 2001. PMID: 11720438 Free PMC article. - Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
Heidenreich A, Gaddipati JP, Moul JW, Srivastava S. Heidenreich A, et al. J Urol. 1998 May;159(5):1725-30. doi: 10.1097/00005392-199805000-00101. J Urol. 1998. PMID: 9554401 - Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions.
Pollock PM, Pearson JV, Hayward NK. Pollock PM, et al. Genes Chromosomes Cancer. 1996 Feb;15(2):77-88. doi: 10.1002/(SICI)1098-2264(199602)15:2<77::AID-GCC1>3.0.CO;2-0. Genes Chromosomes Cancer. 1996. PMID: 8834170 Review.
Cited by
- Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy.
Anichini A, Molla A, Nicolini G, Perotti VE, Sgambelluri F, Covre A, Fazio C, Lofiego MF, Di Giacomo AM, Coral S, Manca A, Sini MC, Pisano M, Noviello T, Caruso F, Brich S, Pruneri G, Maurichi A, Santinami M, Ceccarelli M, Palmieri G, Maio M, Mortarini R; EPigenetic Immune-oncology Consortium AIRC (EPICA) investigators. Anichini A, et al. J Exp Clin Cancer Res. 2022 Nov 17;41(1):325. doi: 10.1186/s13046-022-02529-5. J Exp Clin Cancer Res. 2022. PMID: 36397155 Free PMC article. - Molecular pathways in bladder cancer.
Williams SG, Stein JP. Williams SG, et al. Urol Res. 2004 Dec;32(6):373-85. doi: 10.1007/s00240-003-0345-y. Epub 2004 Nov 13. Urol Res. 2004. PMID: 15551095 Review. - Genetic and epigenetic changes in mammary epithelial cells may mimic early events in carcinogenesis.
Tlsty TD, Crawford YG, Holst CR, Fordyce CA, Zhang J, McDermott K, Kozakiewicz K, Gauthier ML. Tlsty TD, et al. J Mammary Gland Biol Neoplasia. 2004 Jul;9(3):263-74. doi: 10.1023/B:JOMG.0000048773.95897.5f. J Mammary Gland Biol Neoplasia. 2004. PMID: 15557799 Review. - Expressing patterns of p16 and CDK4 correlated to prognosis in colorectal carcinoma.
Zhao P, Hu YC, Talbot IC. Zhao P, et al. World J Gastroenterol. 2003 Oct;9(10):2202-6. doi: 10.3748/wjg.v9.i10.2202. World J Gastroenterol. 2003. PMID: 14562378 Free PMC article. - Distinct cytosine modification profiles define epithelial-to-mesenchymal cell-state transitions.
Lee MK, Brown MS, Wilkins OM, Pattabiraman DR, Christensen BC. Lee MK, et al. Epigenomics. 2022 May;14(9):519-535. doi: 10.2217/epi-2022-0023. Epub 2022 Apr 6. Epigenomics. 2022. PMID: 35382559 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous